Evidence map›Paper›PMID 34065518›Full record

ArticleMicroorganisms2021

Isolation Procedure for CP

Natalie Pauly, Yvonne Klaar, Tanja Skladnikiewicz-Ziemer, Katharina Juraschek, Mirjam Grobbel, Jens André Hammerl, Lukas Hemmers, Annemarie Käsbohrer, Stefan Schwarz, Diana Meemken and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Carbapenem resistance inAIMS microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Natalie PaulyGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.
Yvonne KlaarGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.
Tanja Skladnikiewicz-ZiemerGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.
Katharina JuraschekGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.
Mirjam GrobbelGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.ORCID 0000-0002-8619-1498
Jens André HammerlGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.ORCID 0000-0002-6930-4358
Lukas HemmersState Office for Health and Social Affairs Berlin, D-10639 Berlin, Germany.
Annemarie KäsbohrerGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.ORCID 0000-0003-2966-2713
Stefan SchwarzInstitute of Microbiology and Epizootics, Freie Universität Berlin, D-14163 Berlin, Germany.ORCID 0000-0002-6303-8212
Diana MeemkenInstitute of Food Safety and Food Hygiene, Freie Universität Berlin, D-14163 Berlin, Germany.ORCID 0000-0002-4824-048X
Bernd-Alois TenhagenGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.
Alexandra IrrgangGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung), D-10589 Berlin, Germany.ORCID 0000-0003-1266-9978
Federal Institute for Risk Assessment · DEFreie Universität Berlin · DEUniversity of Veterinary Medicine Vienna · AT

Funding

European Union's Horizon 2020 research and innovation programme 773830German Federal Institute for Risk Assessment 43-001 and 43-002German Federal Ministry of Education and Research (BMBF) 01KI2009D
6 · The paper itself

Abstract

Due to the increasing reports of carbapenemase-producing Enterobacteriaceae (CPE) from livestock in recent years, the European Reference Laboratory for Antimicrobial Resistances (EURL-AR) provided a protocol for their recovery from caecum and meat samples. This procedure exhibited limitations for the detection of CPE with low carbapenem MIC values. Therefore, it was modified by a second, selective enrichment in lysogeny broth with cefotaxime (CTX 1 mg/L) and with meropenem (MEM 0.125 mg/L) at 37 °C under microaerophilic conditions. By Real-time PCR, these enrichments are pre-screened for the most common carbapenemase genes. Another adaptation was the use of in-house prepared MacConkey agar with MEM and MEM+CTX instead of commercial selective agar. According to the EURL-method, we achieved 100% sensitivity and specificity using the in-house media instead of commercial agar, which decreased the sensitivity to ~75%. Comparing the method with and without the second enrichment, no substantial influence on sensitivity and specificity was detected. Nevertheless, this enrichment has simplified the CPE-isolation regarding the accompanying microbiota and the separation of putative colonies. In conclusion, the sensitivity of the method can be increased with slight modifications.

Indexed as

carbapenemaseCPE detectionIsolationselective mediasensitivityspecificity

Identifiers

PMID34065518
PMCPMC8161246
OpenAlexW3162676323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.